| Literature DB >> 21629275 |
Felix W Frueh1, Henry T Greely, Robert C Green, Stuart Hogarth, Sue Siegel.
Abstract
In light of the meeting of the US Food and Drug Administration (FDA) in March 2011 to discuss the regulation of clinical direct-to-consumer (DTC) genetic tests, we have invited five experts to consider the best means of overseeing the ordering and interpretation of these tests. Should these tests be regulated? If so, who, if anyone, should communicate results to consumers?Entities:
Mesh:
Year: 2011 PMID: 21629275 PMCID: PMC3763708 DOI: 10.1038/nrg3026
Source DB: PubMed Journal: Nat Rev Genet ISSN: 1471-0056 Impact factor: 53.242